Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of March 2023. The document serves as a notice regarding the publication of the Annual General Meeting (AGM) 2023 details.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Events
- AGM Announcement: The Notice of the 2023 AGM has been published on the company website and will be distributed to shareholders.
- Meeting Details: The AGM is scheduled for Wednesday, May 3, 2023, at 2:30 pm at the Sofitel London Heathrow, Terminal 5.
- Participation: The meeting will be held in person and broadcast live for electronic shareholder participation.
- Regulatory Compliance: The AGM Notice and Proxy Form are being submitted to the UK Listing Authority in compliance with Listing Rule 9.6.1R of the UK Financial Conduct Authority.
Key Facts for Investor Verification
- Verify the date and location of the 2023 AGM (May 3, 2023, London Heathrow).
- Confirm the availability of the AGM Notice and Proxy Form on the company website and the UK FCA National Storage Mechanism.
- Note that this filing contains no financial results; investors should refer to the company's Form 20-F or quarterly reports for financial data.